Reviews in the Neurosciences

Papers
(The H4-Index of Reviews in the Neurosciences is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Exploring neuroglial signaling: diversity of molecules implicated in microglia-to-astrocyte neuroimmune communication60
A systematic review of transcranial direct current stimulation on eye movements and associated psychological function32
Probiotic effects on anxiety-like behavior in animal models32
Putative neural consequences of captivity for elephants and cetaceans28
Targeting NMDA receptor signaling for therapeutic intervention in brain disorders28
Research progress on astrocyte-derived extracellular vesicles in the pathogenesis and treatment of neurodegenerative diseases25
Frontmatter24
Dominant mechanism in spinal cord injury-induced immunodeficiency syndrome (SCI-IDS): sympathetic hyperreflexia23
Research advancements on nerve guide conduits for nerve injury repair22
Advances in point-of-care platforms for traumatic brain injury: recent developments in diagnostics20
Extracellular histones as damage-associated molecular patterns in neuroinflammatory responses19
Scoping review of the risk factors and time frame for development of post-traumatic hydrocephalus19
Simulation of oscillatory dynamics induced by an approximation of grid cell output19
Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis18
The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses18
Advanced techniques and innovations in peripheral nerve repair: a comprehensive review for clinical and experimental reference18
A review of the application of exercise intervention on improving cognition in patients with Alzheimer’s disease: mechanisms and clinical studies18
An overview of retinal light damage models for preclinical studies on age-related macular degeneration: identifying molecular hallmarks and therapeutic targets17
0.025661945343018